Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus

Virology

Volumn 235, Issue 2, 1997, Pages 252-260

  Liang, Mifang ^a   Guttieri, Mary ^a   Lundkvist, Åke ^b   Schmaljohn, Connie ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; HAMSTER; HUMAN; HUMAN CELL; HYBRIDOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; PUUMALA VIRUS; VIRUS INFECTION;

ANIMALIA; AUTOGRAPHA CALIFORNICA; AUTOGRAPHA CALIFORNICA NUCLEOPOLYHEDROVIRUS; CRICETINAE; CYPOVIRUS; PUUMALA VIRUS; SPODOPTERA FRUGIPERDA; UNIDENTIFIED BACULOVIRUS; UNIDENTIFIED NUCLEAR POLYHEDROSIS VIRUSES;

EID: 0030830110     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8695     Document Type: Article

References (41)

1. Antoniadis A., Grekas D., Rossi C., LeDuc J. Isolation of a hantavirus from a severely ill patient with hemorrhagic fever with renal syndrome in Greece. J. Infect. Dis. 156:1987;1010-1012.
2. Antoniadis A., Antonis S., Papa A., Alexiou-Daniel S., Lampropoulos A., Nichol S. T., Peters C. J., Spiropoulou C. F. Direct genetic detection of Dobrava virus in Greek and Albanian hemorrhagic fever with renal syndrome (HFRS) patients. J. Infect. Dis. 174:1996;407-409.
3. Antoniadis A., LeDuc J., Acritidis N., Alexiou D., Kyparissi A., Saviolakis G. Characteristics of passive immunity against hantavirus infection in rats. Arch. Virol. 105:1989;235-246.
4. Arikawa J., Schmaljohn A. L., Dalrymple J. M., Schmaljohn C. S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 70:1989;615-624.
5. Arikawa J., Yao J., Yoshimatsu K., Takashima I., Hashimoto N. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch. Virol. 126:1992;271-281.
6. Asada H., Balachandra K., Tamura M., Kondo K., Yamanishi K. Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J. Gen. Virol. 70:1989;819-825.
7. Asada H., Tamura M., Kondo K., Dohi Y., Yamanishi K. Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: Generation of cytotoxic T lymphocytes. J. Gen. Virol. 69:1988;2179-2188.
8. Asada H., Tamura M., Kondo K., Okuno Y., Takahashi Y., Dohi Y., Nagai T., Kurata T., Yamanishi K. Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice. J. Gen. Virol. 68:1987;1961-1969.
9. Barbas C. d., Kang A. S., Lerner R. A., Benkovic S. J. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc. Natl. Acad. Sci. USA. 88:1991;7978-7982.
10. Boyd P. N., Lines A. C., Patel A. K. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol. Immunol. 32:1995;1311-1318.
11. Chu Y.-K., Jennings G. B., Schmaljohn C. S. A vaccinia-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul Viruses, but not Puumala virus. J. Virol. 69:1995;6417-6423.
12. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
13. Gustafsson B., Jondal M., Sundqvist V.-A. SPAM-8, a mouse-human heteromyeloma fusion partner in production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. Hum. Antibodies Hybridomas. 2:1991;26-32.
14. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor.
15. Haseman C. A., Capra J. D. Baculovirus expression of antibodies: A method for the expression of complete immunoglobulins in a eukaryotic host. Methods: A Companion to Methods in Enzymology. Volume 2, New Techniques in Antibody Generation. 1991;Academic Press, San Diego. p. 146-158.
16. Hu P., Glasky M. S., Yun A., Alauddin M. M., Hornick J. L., Khawli L. A., Epstein A. L. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system. Hum. Antibodies Hybridomas. 6:1995;57-67.
17. Huggins J. W., Hsiang C. M., Cosgriff T. M., Guang M. Y., Smith J. I., Wu Z. U., LeDuc J. W., Zheng Z. M., Meegan J. M., Wang Q. N., Oland D. D., Gui X. E., Gibbs P. H., Yuan G. H., Zhang T. M. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J. Infect. Dis. 164:1991;1119-1127.
18. Jokinen E., Collan Y., Lahdevirta J. Renal immune complexes in epidemic nephropathy. Lancet. 1977;1012-1013.
19. Jokinen E., Lahdevirta J., Collan Y. Nephropathia epidemica: Immunohistochemical study of pathogenesis. Clin. Nephrol. 9:1978;1-5.
20. Kang A. S., Burton D. R., Lerner R. A. Combinational immunoglobulin libraries in phage lambda. Burton D., Lerner R. Methods: A Companion to Methods in Enzymology. Volume 2, New Techniques in Antibody Generation. 1991;111-118 Academic Press, San Diego.
21. Lee H., Dalrymple J. Manual of Hemorrhagic Fever with Renal Syndrome. 1989;WHO Collaborating Center for Virus Reference and Research, Seoul.
22. Liang M., Chu Y.-K., Schmaljohn C. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology. 217:1996;262-271.
23. Lundkvist Å., Horling J., Athlin L., Rosen A., Niklasson B. Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: A novel method using antigen-coated magnetic beads for specific B cell isolation. J. Gen. Virol. 74:1993;1303-1310.
24. Nakamura T., Yanagihara R., Gibbs C., Gajdusek D. Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice. J. Infect. Dis. 151:1985;691-697.
25. Nakamura T., Yanagihara R., Gibbs J., CJ, Amyx H., Gajdusek G. Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection. Arch. Virol. 86:1985;109-120.
26. O'Reilly D. R., Miller L. K., Luckow V. A. Baculovirus Expression Vectors: A Laboratory Manual. 1992;Freeman, New York.
27. Padlan E. A. Anatomy of the antibody molecule. Mol. Immunol. 31:1994;169-217.
28. Penttinen K., Lahdevirta J., Kekomaki R., Ziola B., Salmi A., Hautanen A., Lindstrom P., Vaheri A., Brummer-Korvenkontio M., Wagner O. Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J. Infect. Dis. 143:1981;15-21.
29. Poul M. A., Cerutti M., Chaabihi H., Ticchioni M., Deramoudt F. X., Bernard A., Devauchelle G., Kaczorek M., Lefranc M. P. Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. Eur. J. Immunol. 25:1995;2005-2009.
30. Schmaljohn C., Chu Y., Schmaljohn A., Dalrymple J. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinant. J. Virol. 64:1990;3162-3170.
31. Schmaljohn C., Hasty S., Dalrymple J., LeDuc J., Lee H., von Bonsdorff C.-H., Brummer-Korvenkontio M., Vaheri A., Tsai T., Regnery H., Goldgaber D., Lee P.-W. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science. 227:1985;1041-1044.
32. Schmaljohn C., Hasty S., Harrison S., Dalrymple J. Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J. Infect. Dis. 148:1983;1005-1012.
33. Sheshberadaran H., Niklasson B., Tkachenko E. Antigenic relationship between hantaviruses analysed by immunoprecipitation. J. Gen. Virol. 69:1988;2645-2651.
34. Temonen M., Mustonen J., Helin H., Pasternack A., Vaheri A., Holthofer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: An immunohistochemical study. Clin. Immunol. Immunopathol. 78:1996;47-55.
35. Van Ypersele de Strihou C., Mery J. Hantavirus-related acute interstitial nephritis in western Europe. Expansion of a world-wide zoonosis. Q. J. Med. 73:1989;941-950.
36. Vapalahti O., Kallio-Kokko H., Salonen E., Brummer-Korvenkontio M., Vaheri A. Cloning and sequencing of Puumala virus Sotkamo strain S and M segments: Evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J. Gen. Virol. 73:1992;829-838.
37. Weyer U., Knight S., Possee R. D. Analysis of very late gene expression byAutographa californica. J. Gen. Virol. 71:1990;1525-1534.
38. Xiao S., Spik K., Li D., Schmaljohn C. Nucleotide and deduced amino acid sequences of the M and S genome segments of two Puumala virus isolates from Russia. Virus Res. 30:1993;97-103.
39. Zeier M., Zoller L., Haussmann W., Andrassy K., Ritz E. The clinical picture and therapy of Hantaan virus infection. Dtsch. Med. Wochenschr. 115:1990;1678-1681.
40. Zhang X., Takashima I., Hashimoto N. Characteristics of passive immunity against hantavirus infection in rats. Arch. Virol. 105:1989;235-246.
41. zu Putlitz J., Kubasek W. L., Duchene M., Marget M., von Specht B.-U., Domdey H. Antibody production in baculovirus-infected insect cells. Biotechnology. 8:1990;651-654.